ARC

Dec 26 2024HEALTH

Meet Professor Deborah O'Connor

Get ready to meet Professor Deborah O'Connor, a big name in the world of gerontological social work. Deborah is Canadian and known globally for her impressive work. A doctoral student, Karen Wong, had the chance to interview Deborah before she retired. The chat wasn’t just a friendly catch-up; it wa

reading time less than a minute
Dec 26 2024EDUCATION

The Curious Debate: Louie and Pereira Weigh In

Imagine you're in a lively classroom debate. Two sides, Louie and Pereira et al. , have something important to say. They're responding to some letters, but don't worry, we'll make it fun and easy to understand. First, let's talk about Louie. They've got a unique take on things. They seem to be the

reading time less than a minute
Dec 26 2024HEALTH

Exploring the Promise of Vagus Nerve Stimulation in Stroke Therapy

Ever heard of the vagus nerve? It's a key player in our body's internal communication network. Lately, scientists have been buzzing about a technique called vagus nerve stimulation (VNS) as a possible game-changer in stroke treatment. This method involves zapping the vagus nerve with tiny electrical

reading time less than a minute
Dec 26 2024HEALTH

Vaccine Clinical Trials: Boosting Capabilities in Nepal

Clinical trials are a big deal when it comes to checking if new vaccines or medicines are safe and work as they should. These trials are tricky and take a lot of time. They need the help of government officials, trial sites, researchers, and the whole health system. In recent years, many of these tr

reading time less than a minute
Dec 26 2024FINANCE

Gold vs Cryptos: Safe Havens in Tough Times

You're probably wondering if gold or cryptocurrencies can save you from tough market times. This study looked at their safe-haven and hedging abilities during events like the COVID-19 pandemic and geopolitical risks. They checked data from 2013 to 2021 every day. Guess what? Neither gold nor cryptos

reading time less than a minute
Dec 26 2024HEALTH

Unraveling the Real-World Success of Enfortumab Vedotin for Advanced Bladder Cancer

Let's dive into the effectiveness of Enfortumab Vedotin (EV) in tackling advanced urothelial carcinoma (a severe form of bladder cancer) in the real world. EV is a unique drug that combines two powerful actions: it targets the nectin-4 protein found in cancer cells and disrupts their structure by in

reading time less than a minute
Dec 26 2024HEALTH

The Uncertain Benefits of Ongoing Treatment for Stomach and Pancreas Neuroendocrine Tumors

Stomach and pancreas neuroendocrine tumors are quite the puzzle for doctors. They're not common and often go unnoticed until it's too late, making them difficult to tackle. When these tumors spread, doctors typically start with platinum-based chemotherapy. But here's where it gets confusing. After t

reading time less than a minute
Dec 26 2024HEALTH

Elderly Care: China vs Australia – A Research Comparison

Ever wondered what sets apart the research on elderly care between China and Australia? Let's dive in. We'll look at the current state of studies, the top contributors, and where each country is focusing its efforts. The aim? To spark some smart collaborations for the future. In China, researchers

reading time less than a minute
Dec 25 2024TECHNOLOGY

Guard Your Data: Keeping Georgia's Surveys Honest

Web surveys are super convenient, but they're also a magnet for cheaters. People fill them out with fake answers, which messes up the results and makes the data useless for scientists and researchers. The problem is, not everyone talks about how to spot and remove these dishonest responses. Think o

reading time less than a minute
Dec 25 2024HEALTH

Dividing the Bladder Cancer Puzzle: Early Growth vs. Spread

Imagine you're looking at two types of bladder cancer under a microscope. At first glance, they might seem similar, like two plants growing close together. But doctors are trying to figure out how to tell them apart. One type, called "early papillary formation, " grows upward like a tiny stem. The o

reading time less than a minute